| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.423 | 12.565 | 10.516 | 12.764 | 20.830 | 26.545 | 26.281 | 26.228 | 28.849 |
| Total Income - EUR | - | 7.423 | 12.565 | 10.516 | 12.765 | 24.588 | 36.777 | 38.585 | 50.084 | 57.002 |
| Total Expenses - EUR | - | 23.480 | 20.988 | 18.585 | 25.240 | 31.266 | 35.635 | 37.744 | 35.056 | 42.023 |
| Gross Profit/Loss - EUR | - | -16.057 | -8.423 | -8.069 | -12.475 | -6.678 | 1.142 | 840 | 15.028 | 14.979 |
| Net Profit/Loss - EUR | - | -16.191 | -8.607 | -8.174 | -12.603 | -6.918 | 774 | 454 | 14.527 | 14.409 |
| Employees | - | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Iridium Farma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 4.264 | 4.258 | 4.180 | 4.170 | 4.022 | 3.543 | 3.554 | 3.543 | 3.523 |
| Current Assets | - | 9.057 | 9.333 | 8.640 | 7.377 | 14.119 | 14.621 | 11.343 | 10.137 | 11.260 |
| Inventories | - | 5.672 | 5.871 | 5.350 | 2.925 | 4.821 | 3.875 | 5.500 | 5.329 | 6.606 |
| Receivables | - | 2.492 | 2.756 | 3.184 | 4.541 | 8.545 | 9.637 | 5.081 | 3.467 | 2.567 |
| Cash | - | 894 | 707 | 106 | -88 | 753 | 1.109 | 762 | 1.340 | 2.088 |
| Shareholders Funds | - | -16.147 | -24.437 | -32.103 | -44.084 | -50.167 | -48.280 | -47.976 | -33.303 | -18.708 |
| Social Capital | - | 45 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 29.468 | 38.029 | 44.970 | 55.631 | 68.308 | 66.444 | 62.873 | 46.983 | 33.492 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Iridium Farma S.r.l.